Related Experiment Videos
Diagnostic assessment of recurrent syncope
Insights
Electrocardiographic monitoring is key for diagnosing cardiac arrhythmia-related syncope. Electrophysiologic studies are most valuable in patients with known heart disease, guiding therapy for conditions like ventricular tachycardia.
Area of Science:
- Cardiology
- Electrophysiology
Background:
- Syncope diagnosis often relies on electrocardiographic monitoring during an event.
- In its absence, electrophysiologic studies (EPS) may identify arrhythmia causes.
- Recurrent syncope warrants EPS primarily in patients with known cardiac disease.
Purpose of the Study:
- To evaluate the utility of electrophysiologic studies in diagnosing syncope.
- To determine the appropriate patient population for cardiac electrophysiologic testing.
- To assess the significance of induced arrhythmias in patients with and without cardiac disease.
Main Methods:
- Review of diagnostic approaches for syncope.
- Analysis of electrophysiologic study yields in different patient groups.
- Comparison of outcomes in patients with and without underlying cardiac disease.
Main Results:
- EPS is most beneficial in patients with underlying cardiac disease, identifying arrhythmias like ventricular tachycardia.
- In patients without cardiac disease, EPS has a low diagnostic yield (10-20%) and syncope often remits spontaneously.
- The significance of induced nonsustained arrhythmias in asymptomatic individuals remains unclear.
Conclusions:
- Cardiac electrophysiologic testing should be reserved for syncope patients with known cardiac disease.
- Further research is needed to understand the implications of induced arrhythmias and spontaneous syncope remission rates.
Abstract:
The definitive diagnosis of a cardiac arrhythmia as the basis for syncope is made by electrocardiographic monitoring during a syncopal episode. In the absence of this evidence, abnormalities demonstrated by an electrophysiologic study may suggest the etiology of syncope. Cardiac electrophysiologic testing in patients with recurrent syncope should probably be limited to patients with underlying cardiac disease. These patients are at a higher risk for sudden death and have a high incidence of electrophysiologic abnormalities. In particular, ventricular tachycardia may be evoked and specific therapy for this abnormality is associated with remission of syncope. In contrast, electrophysiologic studies in patients with no underlying cardiac disease have a very low yield of abnormal findings in the order of 10-20%, and should be performed only when there are reasons to suspect the presence of arrhythmias. Furthermore, in patients with no underlying cardiovascular disease there is a high spontaneous remission rate of syncope and the late incidence of sudden death is low, and related to the presence of other systemic illnesses. At present, the significance of nonsustained ventricular tachycardia or ventricular fibrillation induced during cardiac electrophysiologic studies in patients with no documented arrhythmias is unknown, and further prospective studies are necessary to define appropriate therapy for these patients. Further investigation is also required to clarify the spontaneous remission rate of syncope, as this information is of vital importance in assessing the success of any therapeutic modality.